DE3588244D1 - Rekombinanter Herpes Simplex gB-gD-Impfstoff - Google Patents

Rekombinanter Herpes Simplex gB-gD-Impfstoff

Info

Publication number
DE3588244D1
DE3588244D1 DE3588244T DE3588244T DE3588244D1 DE 3588244 D1 DE3588244 D1 DE 3588244D1 DE 3588244 T DE3588244 T DE 3588244T DE 3588244 T DE3588244 T DE 3588244T DE 3588244 D1 DE3588244 D1 DE 3588244D1
Authority
DE
Germany
Prior art keywords
vaccine
herpes simplex
recombinant herpes
recombinant
simplex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3588244T
Other languages
English (en)
Other versions
DE3588244T2 (de
Inventor
Rae Lyn Burke
Carol Pachl
Pablo D T Vanlenzuela
Mickey S Urdea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/631,669 external-priority patent/US4618578A/en
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DE3588244D1 publication Critical patent/DE3588244D1/de
Publication of DE3588244T2 publication Critical patent/DE3588244T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
DE3588244T 1984-04-06 1985-04-04 Rekombinanter Herpes Simplex gB-gD-Impfstoff Expired - Lifetime DE3588244T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US597784A 1984-04-06 1984-04-06
US06/631,669 US4618578A (en) 1984-07-17 1984-07-17 Expression of glycoprotein D of herpes simplex virus

Publications (2)

Publication Number Publication Date
DE3588244D1 true DE3588244D1 (de) 2003-02-13
DE3588244T2 DE3588244T2 (de) 2003-09-11

Family

ID=27759849

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3588244T Expired - Lifetime DE3588244T2 (de) 1984-04-06 1985-04-04 Rekombinanter Herpes Simplex gB-gD-Impfstoff

Country Status (1)

Country Link
DE (1) DE3588244T2 (de)

Also Published As

Publication number Publication date
DE3588244T2 (de) 2003-09-11

Similar Documents

Publication Publication Date Title
NL930085I1 (nl) Benzoylfenylurea
DK190486D0 (da) Xanthiner
DK603888A (da) Rekombinant virus
DE3650689T2 (de) Rekombinantes inhibin
DK600485A (da) Theophyllin-retardpraeparat
KR860005151A (ko) 측로형 송풍기
FI832632A0 (fi) Framstaellning av herpes simplex-virusproteiner
DK256385A (da) Interferonpraeparat
DK62386D0 (da) Vaccine
DK62486D0 (da) Vaccine
DK377787D0 (da) Interferonfragmenter
NZ214652A (en) Vaccine against fasciola
DK389085D0 (da) Vaccine-polypeptider
GB8531508D0 (en) Vaccine
DK219187A (da) Rekombinant-virus
GB8400529D0 (en) Helminths vaccines
DE3588244T2 (de) Rekombinanter Herpes Simplex gB-gD-Impfstoff
NZ214660A (en) Ovine foot-rot vaccine
ZA858789B (en) Vaccines
DK567786D0 (da) Ikke-adjuvansholdig vaccine
DK596888A (da) Rekombinant lymfotoksin
DK477185A (da) Vacciner
GB8406901D0 (en) Virus vaccine
GB8400683D0 (en) Vaccine
IE842847L (en) Vaccine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition